Department of Emergency Medicine, Yale School of Medicine, 464 Congress Ave., Suite 260, New Haven, CT, 06519, USA.
Department of Health Policy and Management, Yale School of Public Health, Yale Cancer Center, New Haven, CT, USA.
Addict Sci Clin Pract. 2019 Sep 2;14(1):29. doi: 10.1186/s13722-019-0159-z.
Tobacco use is a chronic relapsing disease, and remains the leading cause of preventable death in much of the world. Increasingly, tobacco use, chiefly cigarette smoking, is being framed as a chronic disease, with periods of use and periods of abstinence. An implicit component of this conceptualization is that treatment-both counseling and pharmacotherapy-may be needed at various intervals for extended periods of time, perhaps over an individual's lifetime. This would mirror the treatment of other chronic conditions, such as diabetes, hypertension, or hyperlipidemia. Yet, clinical trials of tobacco dependence treatment still generally model outcome measures in terms of cessation, abstinence, or quitting, measured at discrete time points. This reinforces the notion that smoking, or tobacco dependence, is a dichotomous condition, and that one is either "cured," or not. Although the goal of treating tobacco dependence is to ensure long-term abstinence (i.e. "quitting"), this model is discordant with clinical reality, in which of periods of tobacco use are interspersed with periods of abstinence. Hence, the goal of treatment is to lengthen the duration of the latter, while shortening the duration of the former. In the clinical arena, this dichotomous model of tobacco use is reflected in electronic health records, where smoking is generally categorized as current, former, or never. We propose that clinicians move away from the dichotomous categorization of tobacco use, and adopt methods used to categorize the status of other chronic conditions. Specifically, biomarkers such as carbon monoxide, cotinine, and anabasine, measured at regular intervals, can provide clinicians with much clearer, clinically relevant and actionable assessments of current tobacco use by their patients. This can be done without making reference to dichotomous states such as current or former use of tobacco. In psychological terms, one can frame tobacco use in terms of states, attributes in specific situations at discrete moments in time, rather than the more durable traits.
吸烟是一种慢性复发性疾病,在世界上许多地方仍然是可预防死亡的主要原因。越来越多的人认为吸烟主要是吸烟,是一种慢性疾病,有使用期和禁欲期。这种概念化的一个隐含组成部分是,在不同的时间间隔内,可能需要在个人的一生中,需要进行治疗——包括咨询和药物治疗。这将反映出对其他慢性疾病的治疗,如糖尿病、高血压或高脂血症。然而,烟草依赖治疗的临床试验仍然普遍以停止、禁欲或戒烟为终点来衡量结果,这些结果是在离散的时间点上测量的。这强化了这样一种观念,即吸烟或烟草依赖是一种二分状态,要么“治愈”,要么不“治愈”。尽管治疗烟草依赖的目标是确保长期禁欲(即“戒烟”),但这种模式与临床现实不符,因为在临床现实中,吸烟或烟草依赖是一种二分状态,人们要么“治愈”,要么不“治愈”。在临床领域,这种二分模型反映在电子健康记录中,其中吸烟通常被归类为当前、过去或从不吸烟。我们建议临床医生摆脱对烟草使用的二分分类,并采用用于分类其他慢性疾病状态的方法。具体来说,定期测量一氧化碳、可替宁和烟碱等生物标志物,可以为临床医生提供更清晰、更具临床相关性和可操作性的患者当前吸烟情况评估。这可以在不参考吸烟的当前或过去使用等二分状态的情况下完成。从心理学的角度来看,可以根据状态来描述吸烟情况,即特定情况下的特定属性,而不是更持久的特征。